Noninvasive preimplantation genetic testing for aneuploidy in spent blastocyst media will substitute for trophectoderm biopsy

Fertile Battle

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Published
Like Comment
Related Content

VOLUME 115, ISSUE 4, P840

Author:

Carlos Simon, M.D., Ph.D.

Abstract:

The discovery of cell-free fetal deoxyribonucleic acid in maternal plasma has enabled a paradigm shift in prenatal testing (1). Since its inception, noninvasive prenatal testing (niPGT) has dramatically changed clinical practice in prenatal care, allowing safer and earlier detection of genetic conditions of the fetus during the first trimester of pregnancy (2).

Read the full text here. 

Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.